Stacking
Using two or more peptides simultaneously to achieve complementary or synergistic effects. Common stacks include CJC-1295 + Ipamorelin for GH release and BPC-157 + TB-500 for tissue healing.
Frequently Asked Questions
What is Stacking?
Why is Stacking important in peptide research?
Related Terms
The practice of using a peptide for a set period (on-cycle) followed by a break (off-cycle) to maintain receptor sensitivity, reduce side effects, and prevent tolerance. Typical cycles range from 4–12 weeks on, 2–4 weeks off.
Pulsatile dosingA dosing strategy that mimics the body’s natural pulsatile hormone release patterns. Used with growth hormone secretagogues to prevent receptor desensitization and maintain physiological GH release.
Related Peptide Profiles
A synthetic growth hormone-releasing hormone (GHRH) analog that stimulates pulsatile GH secretion. Available with or without DAC (Drug Affinity Complex).
IpamorelinA selective growth hormone secretagogue that stimulates GH release through the ghrelin receptor with minimal effect on cortisol or prolactin.
BPC-157Body Protection Compound-157, a synthetic pentadecapeptide derived from human gastric juice studied for tissue repair, gut healing, and anti-inflammatory effects.
TB-500A synthetic version of Thymosin Beta-4, a 43-amino acid peptide that promotes healing through actin upregulation, angiogenesis, and inflammation reduction.